- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Topical Vancomycin Reduces Surgical Wound Infections Without Increasing Kidney Injury, suggests study

A new study published in The Annals of Thoracic Surgery showed that topical vancomycin markedly decreased the incidence of surgical wound infections (SWI) of grade 2 or above, without elevating the likelihood of acute kidney injury (AKI).
Infections of the sternal wound represent serious complications after cardiac surgery, leading to greater morbidity, extended hospital stays, and increased healthcare expenses. Although surgical methods and perioperative antibiotic prophylaxis have improved, preventing postoperative infections continues to be difficult. The use of topical vancomycin has been proposed as a preventive measure due to its broad-spectrum effectiveness against Gram-positive bacteria, especially staphylococci. Its potential to reduce sternal wound infections of grade 2 or higher requires clinical investigation. Thereby, this study assessed the efficacy and safety of applying vancomycin paste topically on the sternal edges to prevent sternal wound infection.
This trial randomly assigned 360 adult patients undergoing elective full sternotomy cardiac surgery in a 1:1 ratio to receive either vancomycin paste or normal saline. The primary outcome measured was the incidence of surgical wound infection within 90 days following surgery. Secondary outcomes comprised postoperative acute kidney injury, development of resistant pathogens, and systemic exposure to vancomycin.
The occurrence of grade 2 or higher sternal wound infection within 90 days was notably lower in the vancomycin group compared to the placebo group (1 out of 180, 0.6% versus 7 out of 180, 3.9%, p = .031). The sub-distribution hazard ratio was 0.14 (p = .065). The rate of deep SWI was 0.6% when compared to 2.8% (p = .099).
The frequency of acute kidney injury was similar between the two groups (31.7% versus 28.9%, p = .251), including among patients with chronic kidney disease (CKD) stages 3 or higher. Systemic vancomycin levels were minimal and decreased over time in patients not receiving dialysis. However, concentrations exceeding 10-20 mg/L remained in some individuals undergoing hemodialysis.
3 instances of vancomycin-resistant Enterococcus from different sources were detected in the vancomycin-treated patients with CKD stage 3 or above or those on hemodialysis. Overall, the application of topical vancomycin decreased the occurrence of grade 2 or more severe surgical wound infections without elevating the likelihood of acute kidney injury. Systemic absorption was minimal, apart from in patients receiving hemodialysis.
Source:
Tsai, M.-T., Li, C.-Y., Chen, Y.-W., Hu, Y.-N., Kan, C.-D., Chou, C.-H., & Roan, J.-N. (2026). Topical vancomycin for prevention of grade 2 or higher sternal wound infection after cardiac surgery: A randomized controlled trial. The Annals of Thoracic Surgery. https://doi.org/10.1016/j.athoracsur.2026.09.057
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

